Preferences help
enabled [disable] Abstract
Number of results
2013 | 8 | 4 | 493-498
Article title

Risk factors in patients with herpes zoster infections: case-control study

Title variants
Languages of publication
The aim of this study was to determine the prevalence of chronic disease and the risk factors for herpes zoster infection. In this case-control study medical records were collected from 55 patients who presented with herpes zoster and 54 patients in a control group who presented with gastroenterocolitis. Both groups were treated at the Clinic for Infectious Diseases, University Clinical Hospital Mostar from January, 2005 to December, 2010. When we compared the herpes zoster group with the control group, we did not demonstrate any significant difference in the overall prevalence of chronic diseases. However, the prevalence of diabetes and cancer was statistically higher when compared to the control group. A statistically significant difference in the number of cigarette smokers was not observed, whereas the number who consumed alcohol in the herpes zoster group was significantly higher compared to the control group. The correlation between alcohol and herpes zoster could help in solving the reactivation mechanism of VZV.
Physical description
1 - 8 - 2013
12 - 6 - 2013
  • [1] Cohen J.I., The varicella-zoster virus genome, Curr Top Microbiol Immunol, 2010, 342, 1–14 DOI: 10.1007/82_2010_10[Crossref]
  • [2] Seward J., Jumaan A., VSV: persistence in the population, In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P. S., Roizman B., Whitley R. et al. (Eds), Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge: Cambridge University Press, 2007
  • [3] Moffat J., Ku C.C., Zerboni L., Sommer M., Arvin A., VZV: pathogenesis and the disease consequences of primary infection, In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P. S., Roizman B., Whitley R. et al. (Eds), Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge: Cambridge University Press, 2007
  • [4] Liesegang T.J., Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity, Ophthalmology, 2008, 115, S3–12 DOI: 10.1016/j.ophtha.2007.10.009[Crossref][WoS]
  • [5] Arvin A., Abendroth A., VZV: immunobiology and host response, In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P. S., Roizman B., Whitley R. et al. (Eds), Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge: Cambridge University Press 2007
  • [6] Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al., Epidemiology of varicella zoster virus infection in Canada and the United Kingdom, Epidemiol Infect, 2001, 127, 305–314[WoS]
  • [7] Glynn C., Crockford G., Gavaghan D., Cardno P., Price D., Miller J., Epidemiology of shingles, J R Soc Med, 1990, 83, 617–619
  • [8] Wareham D.W., Breuer J., Herpes zoster, BMJ, 2007, 334, 1211–1215 DOI: 10.1136/bmj.39206.571042.AE[Crossref]
  • [9] Liesegang T.J., Herpes zoster virus infection, Curr Opin Ophthalmol, 2004, 15, 531–536
  • [10] van Wijck A.J., Wallace M., Mekhail N., van Kleef M., Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia, Pain Pract, 2011, 11, 88–97 DOI: 10.1111/j.1533-2500.2010.00428.x[Crossref]
  • [11] Chidiac C., Bruxelle J., Daures J.P., Hoang-Xuan T., Morel P., Leplege A., et al., Characteristics of patients with herpes zoster on presentation to practitioners in France, Clin Infect Dis, 2001, 33, 62–69 DOI: 10.1086/320884[Crossref]
  • [12] Thomas S.L., Hall A.J., What does epidemiology tell us about risk factors for herpes zoster?, Lancet Infect Dis, 2004, 4, 26–33
  • [13] Leung J., Harpaz R., Baughman A.L., Heath K., Loparev V., Vazquez M., et al., Evaluation of laboratory methods for diagnosis of varicella, Clin Infect Dis, 2010, 51, 23–32 DOI: 10.1086/653113[Crossref]
  • [14] Opstelten W., Eekhof J., Neven A.K., Verheij T., Treatment of herpes zoster, Can Fam Physician, 2008, 54, 373–377
  • [15] Alper B.S., Lewis P.R., Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?, J Fam Pract, 2000, 49, 255–264
  • [16] Lancaster T., Silagy C., Gray S., Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials, Br J Gen Pract, 1995, 45, 39–45
  • [17] Wood M.J., Johnson R.W., McKendrick M.W., Taylor J., Mandal B.K., Crooks J., A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster, N Engl J Med, 1994, 330, 896–900 DOI: 10.1056/NEJM199403313301304[Crossref]
  • [18] Berry J.D., Petersen K.L., A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster, Neurology, 2005, 65, 444–447 DOI: 10.1212/01.wnl.0000168259.94991.8a[Crossref]
  • [19] Schmader K., Herpes zoster in older adults, Clin Infect Dis, 2001, 32, 1481–1486 DOI: 10.1086/320169[Crossref]
  • [20] Schmader K., George L.K., Burchett B.M., Pieper C.F., Hamilton J.D., Racial differences in the occurrence of herpes zoster, J Infect Dis, 1995, 171, 701–704
  • [21] Okamoto S., Hata A., Sadaoka K., Yamanishi K., Mori Y., Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals, J Infect Dis, 2009, 200, 1606–1610 DOI: 10.1086/644646[WoS][Crossref]
  • [22] Strangfeld A., Listing J., Herzer P., Liebhaber A., Rockwitz K., Richter C., et al., Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents, JAMA, 2009, 301, 737–744 DOI: 10.1001/jama.2009.146[Crossref]
  • [23] Schuchter L.M., Wingard J.R., Piantadosi S., Burns W.H., Santos G.W., Saral R., Herpes zoster infection after autologous bone marrow transplantation, Blood, 1989, 74, 1424–1427
  • [24] Toyama N., Shiraki K., Society of the Miyazaki Prefecture D., Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture, J Med Virol, 2009, 81, 2053–2058 DOI: 10.1002/jmv.21599[Crossref]
  • [25] Joesoef R.M., Harpaz R., Leung J., Bialek S.R., Chronic medical conditions as risk factors for herpes zoster, Mayo Clinic proceedings Mayo Clinic, 2012, 87, 961–967 DOI: 10.1016/j.mayocp.2012.05.021[WoS][Crossref]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.